ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Isis Asset Man

Isis Asset Man (ISIS)

0.00
0.00
(0.00%)
終了 12月13日 1:30AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

ISIS 最新ニュース

Isis Pharmaceuticals to Present at the 28th Annual J.P. Morgan Healthcare Conference

CARLSBAD, Calif., Jan. 6 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today announced that management will present a company overview...

Excaliard Initiates Phase 2 Trials in U.S. for its Skin Scarring Drug, EXC 001

CARLSBAD, Calif., Jan. 5 /PRNewswire/ -- Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces...

Isis Pharmaceuticals to Receive $10 Million From OncoGenex' License of OGX-011 to Teva

OGX-011 Phase 3 Studies in First- and Second-Line Advanced Prostate Cancer and Non-Small Cell Lung Cancer Expected to Begin in 2010 and Early 2011 CARLSBAD, Calif., Dec. 21 /PRNewswire-FirstCall/...

Isis Pharmaceuticals (Nasdaq: ISIS) Letter to Shareholders

CARLSBAD, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Dear Isis Supporters and Shareholders, I would like to start by thanking you for your continuing support of Isis. We believe we are at one of...

Isis Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference

CARLSBAD, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today announced that management will present a company...

Isis Pharmaceuticals to Present at Morgan Stanley's Global Healthcare Unplugged Conference

CARLSBAD, Calif., Sept. 9 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today announced that management will present a company...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

- Conference Call Webcast Thursday, August 6, 08:30 a.m. EDT at www.isispharm.com CARLSBAD, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) today announced its...

Isis Pharmaceuticals to Present at Canaccord Adams' 29th Annual Global Growth Conference

CARLSBAD, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), the leader in antisense therapeutics, today announced that management will present a company overview...

OncoGenex Appoints New CFO and Board Member

VANCOUVER, Feb. 14 /PRNewswire-FirstCall/ -- OncoGenex Technologies Inc., announced the appointment of Mr. Stephen Anderson as Chief Financial Officer and Mr. Tom Bailey as a member of the Board...

OncoGenex Announces Completion of $12.8 Million Venture Financing

VANCOUVER, Aug. 16 /PRNewswire-FirstCall/ -- OncoGenex Technologies Inc., a clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancer, announced the...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
SCESurface Transforms Plc
0.415p
(33.87%)
87.29M
STKStreaksai Plc
1.175p
(30.56%)
8.27M
ORCAOrcadian Energy Plc
11.25p
(28.57%)
1.22M
PMGParkmead Group (the) Plc
18.50p
(27.59%)
2.43M
ORCPOracle Power Plc
0.0355p
(18.33%)
1.37B
STEMSthree Plc
264.50p
(-26.73%)
2.62M
TANDTan Delta Systems Plc
17.50p
(-25.53%)
22k
SYMESupply@me Capital Plc
0.0027p
(-23.94%)
358.58M
MTCMothercare Plc
3.30p
(-20.48%)
68.39k
BEMBeowulf Mining Plc
15.00p
(-18.92%)
63.92k
ORCPOracle Power Plc
0.0355p
(18.33%)
1.37B
TRPTower Resources Plc
0.0265p
(1.92%)
563.89M
NTVONativo Resources Plc
0.0024p
(0.00%)
476.73M
SYMESupply@me Capital Plc
0.0027p
(-23.94%)
358.58M
SNDASunda Energy Plc
0.0725p
(11.54%)
307.11M

最近閲覧した銘柄

Delayed Upgrade Clock